Labcorp Holdings, Inc. (LH)
366.57
+3.27
(+0.90%)
USD |
NYSE |
Nov 06, 16:00
366.57
0.00 (0.00%)
Pre-Market: 20:00
Labcorp Holdings Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2010 | 2.70M |
| September 30, 2010 | 3.00M |
| June 30, 2010 | 3.00M |
| Date | Value |
|---|---|
| March 31, 2010 | 3.40M |
| December 31, 2009 | 2.70M |
| September 30, 2009 | 2.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -- |
| OPKO Health, Inc. | 32.18M |
| Myriad Genetics, Inc. | 26.50M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 9.855M |